RecruitingNCT06839300
The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study
Sponsor
AO Foundation, AO Spine
Enrollment
260 participants
Start Date
Feb 9, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
To determine the accuracy of serum NF-L and GFAP levels (ie the biomarkers) at different time points postinjury for predicting the severity of neurologic impairment at 6 months postinjury as either motor complete (AIS grade A/B) or motor incomplete (AIS grade C/D) a group of patients who suffer traumatic spinal fracture and/or dislocation of the spinal column but without neurologic injury will be enrolled as non-SCI spine trauma control participants.
Eligibility
Min Age: 19 Years
Inclusion Criteria12
- Age ≥ 19 years
- Blunt (non-penetrating) traumatic SCI
- Baseline neurologic impairment deemed "complete" (AIS grade A) or "incomplete" (AIS grade B, C, or D) based on clinical history/examination and/or diagnostic imaging
- Bony spinal level involvement between C0 and L1, inclusive
- Ability to have initial blood sample drawn within 24 hours of injury
- Treated either surgically or non-surgically
- Ability to provide informed consent according to the IRB/EC defined and approved procedures
- Age ≥ 19 years
- Traumatic spinal fracture and/or dislocation between C0 and L1 (inclusive) without SCI
- Treated either surgically or nonsurgically
- Ability to have initial blood sample drawn within 24 hours of injury
- Ability to provide informed consent according to the IRB/EC defined and approved procedures
Exclusion Criteria8
- Penetrating SCI (eg, gunshot, stab)
- Previous SCI
- Isolated spinal injury below L1
- Isolated radiculopathy without fracture
- Isolated cauda equina injury
- Patients with known diagnosis of multiple sclerosis
- Preexisting thromboembolic disease or coagulopathy (disorders related to blood clotting), such as hemophilia or von Willebrand disease
- Patients who in the investigator's opinion will not be compliant with the study procedures and patients who have any other conditions/injuries that in the investigator's opinion would render the study procedures dangerous
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06839300
Related Trials
Non-invasive Spinal Cord Stimulation and Blood Pressure Regulation After Spinal Cord Injury
NCT075040552 locations
Clinical Investigation to Validate the Safety and Performance of Integrating Functional Electrical Stimulation Into the ABLE Exoskeleton
NCT075506991 location
Neuromodulation to Improve Grasping Function After SCI
NCT074339591 location
ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury
NCT072349032 locations
NIRS MONITORING OF SPINAL CORD ISCHEMIA IN AORTIC SURGERY
NCT075416121 location